rs11999454

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_012144.4(DNAI1):​c.1460T>G​(p.Val487Gly) variant causes a missense change. The variant allele was found at a frequency of 0.0127 in 1,614,028 control chromosomes in the GnomAD database, including 846 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.028 ( 139 hom., cov: 32)
Exomes 𝑓: 0.011 ( 707 hom. )

Consequence

DNAI1
NM_012144.4 missense

Scores

18

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:9

Conservation

PhyloP100: 3.84

Publications

11 publications found
Variant links:
Genes affected
DNAI1 (HGNC:2954): (dynein axonemal intermediate chain 1) This gene encodes a member of the dynein intermediate chain family. The encoded protein is part of the dynein complex in respiratory cilia. The inner- and outer-arm dyneins, which bridge between the doublet microtubules in axonemes, are the force-generating proteins responsible for the sliding movement in axonemes. The intermediate and light chains, thought to form the base of the dynein arm, help mediate attachment and may also participate in regulating dynein activity. Mutations in this gene result in abnormal ciliary ultrastructure and function associated with primary ciliary dyskinesia and Kartagener syndrome. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2013]
DNAI1 Gene-Disease associations (from GenCC):
  • primary ciliary dyskinesia 1
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, PanelApp Australia
  • primary ciliary dyskinesia
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.001478523).
BP6
Variant 9-34512395-T-G is Benign according to our data. Variant chr9-34512395-T-G is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 163165.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.113 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
DNAI1NM_012144.4 linkc.1460T>G p.Val487Gly missense_variant Exon 15 of 20 ENST00000242317.9 NP_036276.1 Q9UI46-1A0A140VJI0
DNAI1NM_001281428.2 linkc.1472T>G p.Val491Gly missense_variant Exon 15 of 20 NP_001268357.1 Q9UI46A0A087WWV9

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
DNAI1ENST00000242317.9 linkc.1460T>G p.Val487Gly missense_variant Exon 15 of 20 1 NM_012144.4 ENSP00000242317.4 Q9UI46-1
DNAI1ENST00000614641.4 linkc.1472T>G p.Val491Gly missense_variant Exon 15 of 20 5 ENSP00000480538.1 A0A087WWV9
DNAI1ENST00000470169.5 linkn.395T>G non_coding_transcript_exon_variant Exon 3 of 6 5 ENSP00000434296.1 H0YDT9

Frequencies

GnomAD3 genomes
AF:
0.0282
AC:
4294
AN:
152036
Hom.:
138
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0608
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0463
Gnomad ASJ
AF:
0.00231
Gnomad EAS
AF:
0.121
Gnomad SAS
AF:
0.0274
Gnomad FIN
AF:
0.0125
Gnomad MID
AF:
0.0348
Gnomad NFE
AF:
0.00159
Gnomad OTH
AF:
0.0258
GnomAD2 exomes
AF:
0.0344
AC:
8656
AN:
251300
AF XY:
0.0290
show subpopulations
Gnomad AFR exome
AF:
0.0644
Gnomad AMR exome
AF:
0.110
Gnomad ASJ exome
AF:
0.00238
Gnomad EAS exome
AF:
0.131
Gnomad FIN exome
AF:
0.0137
Gnomad NFE exome
AF:
0.00184
Gnomad OTH exome
AF:
0.0191
GnomAD4 exome
AF:
0.0110
AC:
16142
AN:
1461874
Hom.:
707
Cov.:
33
AF XY:
0.0107
AC XY:
7789
AN XY:
727234
show subpopulations
African (AFR)
AF:
0.0650
AC:
2175
AN:
33480
American (AMR)
AF:
0.102
AC:
4552
AN:
44718
Ashkenazi Jewish (ASJ)
AF:
0.00191
AC:
50
AN:
26136
East Asian (EAS)
AF:
0.113
AC:
4489
AN:
39696
South Asian (SAS)
AF:
0.0234
AC:
2014
AN:
86252
European-Finnish (FIN)
AF:
0.0121
AC:
649
AN:
53420
Middle Eastern (MID)
AF:
0.0109
AC:
63
AN:
5768
European-Non Finnish (NFE)
AF:
0.00105
AC:
1163
AN:
1112008
Other (OTH)
AF:
0.0163
AC:
987
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.476
Heterozygous variant carriers
0
1037
2074
3111
4148
5185
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
256
512
768
1024
1280
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0283
AC:
4310
AN:
152154
Hom.:
139
Cov.:
32
AF XY:
0.0290
AC XY:
2158
AN XY:
74384
show subpopulations
African (AFR)
AF:
0.0610
AC:
2532
AN:
41514
American (AMR)
AF:
0.0464
AC:
710
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
0.00231
AC:
8
AN:
3470
East Asian (EAS)
AF:
0.121
AC:
625
AN:
5174
South Asian (SAS)
AF:
0.0270
AC:
130
AN:
4822
European-Finnish (FIN)
AF:
0.0125
AC:
132
AN:
10582
Middle Eastern (MID)
AF:
0.0340
AC:
10
AN:
294
European-Non Finnish (NFE)
AF:
0.00159
AC:
108
AN:
67974
Other (OTH)
AF:
0.0260
AC:
55
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
204
408
611
815
1019
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
48
96
144
192
240
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0140
Hom.:
172
Bravo
AF:
0.0363
TwinsUK
AF:
0.00108
AC:
4
ALSPAC
AF:
0.00182
AC:
7
ESP6500AA
AF:
0.0611
AC:
269
ESP6500EA
AF:
0.00140
AC:
12
ExAC
AF:
0.0328
AC:
3978
Asia WGS
AF:
0.0770
AC:
265
AN:
3478
EpiCase
AF:
0.00164
EpiControl
AF:
0.00231

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:9
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Primary ciliary dyskinesia Benign:4
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Sep 16, 2020
Natera, Inc.
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Jan 12, 2015
Ambry Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

not specified Benign:2
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 21, 2013
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Val487Gly in exon 15 of DNAI1: This variant is not expected to have clinical sig nificance because it has been identified in 6.1% (269/4406) of African American chromosomes from a broad population by the NHLBI Exome Sequencing Project (http: //evs.gs.washington.edu/EVS; dbSNP rs11999454). -

not provided Benign:2
Nov 12, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Kartagener syndrome Benign:1
Mar 06, 2017
Counsyl
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This submission and the accompanying classification are no longer maintained by the submitter. For more information on current observations and classification, please contact variantquestions@myriad.com. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.065
BayesDel_addAF
Benign
-0.50
T
BayesDel_noAF
Benign
-0.37
CADD
Benign
13
DANN
Benign
0.87
DEOGEN2
Benign
0.0033
T;T
Eigen
Benign
-0.92
Eigen_PC
Benign
-0.73
FATHMM_MKL
Benign
0.0042
N
LIST_S2
Benign
0.40
T;T
MetaRNN
Benign
0.0015
T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
-1.7
.;N
PhyloP100
3.8
PrimateAI
Benign
0.30
T
PROVEAN
Benign
4.3
.;N
REVEL
Benign
0.19
Sift
Benign
1.0
.;T
Sift4G
Benign
1.0
T;T
Polyphen
0.0
.;B
Vest4
0.023
MPC
0.15
ClinPred
0.00073
T
GERP RS
3.5
Varity_R
0.042
gMVP
0.29
Mutation Taster
=90/10
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.15
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs11999454; hg19: chr9-34512393; COSMIC: COSV54279474; COSMIC: COSV54279474; API